Search for: "BASF Corp. v. United States"
Results 1 - 16
of 16
Sorted by Relevance
|
Sort by Date
4 Jun 2012, 3:00 am
Corp. v. [read post]
10 Apr 2012, 3:00 am
In the first, NML Capital, Ltd. v. [read post]
24 Mar 2009, 3:46 pm
rejected Plaintiffs' argument that an antitrust stalwart, United States v. [read post]
25 Mar 2022, 2:25 pm
See BASF Corp. v. [read post]
19 May 2022, 3:54 pm
BASF Corp. v. [read post]
4 Sep 2018, 9:43 am
BASF Corp. v. [read post]
13 Jan 2009, 2:19 pm
United States Dept. of Interior, No. 08-30069 (5th Cir. [read post]
30 Mar 2021, 5:00 am
United States, 293 F. 1013 (D.C. [read post]
18 Jan 2018, 10:20 am
United States v. [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
9 Apr 2015, 9:33 am
Corp. v. [read post]
10 Jul 2012, 5:02 am
BASF Corp., No. 4:04CV3356, 2007 WL 3342423 (D. [read post]
5 Jun 2008, 7:15 pm
BASF Corp., 2007 WL 3342423 (D. [read post]
28 Oct 2010, 3:03 pm
Corp. v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
